medigraphic.com
ISSN 1561-2988 (Print)

2020, Number 4

<< Back Next >>

Rev Cubana Farm 2020; 53 (4)

Identification of adverse reactions to drugs in a second-level Hospital of Ecuador

Miranda BA, Amangandi TF, Cunalata YV, Toaquiza AC

Language: Spanish
References: 23
Page: 1-14
PDF size: 370.78 Kb.


ABSTRACT

Introduction: Medications help maintain and increase the quality of life of patients. However, the occurrence of adverse reactions as a result of their consumption has become a public health concern worldwide.
Objective: To identify adverse reactions to drugs in a second-level hospital in Ecuador, in order to increase the safety of patients during their pharmacological treatment.
Methods: This was a descriptive, cross-sectional and field study, carried out in the period from November 2019 to January 2020. The universe was made up of the patients from the surgery and internal medicine departments (562 and 859, respectively). The sample was made up of 109 and 152 patients, respectively, who met the selection criteria.
Results: Among the medical records of the surgical area, 9.17% of adverse drug reactions were detected, as well as 10.53% in the internal medicine area. The most prevalent reactions included dizziness (40% accounted for surgery and 18.75% accounted for internal medicine) and nausea (20% for surgery and 18.75% for internal medicine). Gastrointestinal diseases were recognized as the most frequent hospital diagnosis among patients who had suspected reactions to medications (acute appendicitis accounted for 25.96% and cholelithiasis accounted for 31.25%). Metformin (35.35% for surgery) and tramadol (37.5% for internal medicine) were the most common drugs involved in the occurrence of adverse reactions. According to their causal relationship, possible adverse reactions were found in a higher percentage and the minor ones manifested according to the level of severity.
Conclusions: Adverse drug reactions should be considered as a risk against patient health and stability. Therefore, it puts the health system on alert to consider more rigorous mechanisms in the application and compliance of a robust pharmacovigilance system.


REFERENCES

  1. Rodríguez R, GómezB, Rodríguez Y, Díaz M. Las reacciones adversas como causa de hospitalización. Correo Científico Médico (CCM). 2019 [acceso 20/09/2020];23(1):223-43. Disponible en: https://www.medigraphic.com/cgibin/ new/resumen.cgi?IDARTICULO=88322

  2. Goienetxe E, Garrido S, Lizaso M. Reacción Adversa a los Medicamentos-Dermatología y Alergia. Sevicio Nac salud Osasunbidea. 2012 [acceso 13/09/2020]; p.1-4. Disponible en: http://www.cfnavarra.es/salud/PUBLICACIONES/Libro%20electronico%20de%20temas %20de%20Urgencia/20.Dermatologia%20y%20Alergia/Reacciones%20adversas%20medi camentosas.pdf

  3. BIORED. Manual de farmacovigilancia para pacientes. Buenos Aires: FEDEPOF; 2017 [acceso 25/04/2020]. Disponible en: http://fadepof.org.ar/downloads/MANUALFARMACOVIGILANCIADIGITAL_BIORED SUR.pdf

  4. Amado Tineo J, Vásquez Alva R, Rojas Moya C, Oscanoa T. Reacción adversa a medicamentos como causa de hospitalización de emergencia de adultos mayores. Acta Médica Perú. 2014 [acceso 20/08/2020];31(4):228-33. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1728-59172014000400005

  5. João M, Castañeda I, Lara H, Furones J. Reacciones adversas por antipalúdicos en hospitales centrales y provinciales de Angola. Rev Cub Sal Públ. 2018 [acceso 14/09/2020];44(1):86-99. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662018000100086&lng=es

  6. Jiménez ÓE, Navarro C, Gonzales F, Lanuza F, Montesa Lou C. Análisis de la incidencia y de las características clínicas de las RAMs en el medio hospitalario. Rev. Esp. Salud Publica. 2017 [acceso 14/09/2020]:1-17. Disponible en: http://scielo.isciii.es/scielo.php?pid=S1135- 57272017000100424&script=sci_arttext&tlng=pt

  7. Geer MI, Koul PA, Tanki SA, Shah MY. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital. J Pharmacol Toxicol Methods 2016;81:323–34. DOI: 10.1016/j.vascn.2016.04.011

  8. Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies. Drug Saf. 2015;38(5):437-53. DOI: 10.1007/s40264-015-0281-0

  9. Rangel Meza CR, Roja S, López M, Caviedes G. Prevalencia y factores asociados a la presencia de reacciones adversas a medicamentos en los pacientes tratados por medicina interna en el Hospital Universitario Hernando Moncaleano Perdomo. Rev Médica Risaralda. 2016 [acceso 14/09/2020];22(2):87-90. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/lil-786679

  10. Romero K, Segura J. Sistema de farmacovigilancia para pacientes del área de hospitalización de un hospital del Ecuador. Rev Cubana Farm. 2017 [acceso 14/09/2020];51(4):1–14. Disponible en: http://revfarmacia.sld.cu/index.php/far/article/view/261

  11. Schmiedl S, Rottenkolber M, Szymanski J, Drewelow B, Siegmund W, Hippius M, et al. Preventable ADRs leading to hospitalization-results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients. Expert Opin Drug Saf. 2018;17(2):125-37. DOI: 10.1080/14740338.2018.1415322

  12. Jennings E, Gallagher P, O’Mahony D. Detection and prevention of adverse drug reactions in multi-morbid older patients. Age Ageing. 2019 [acceso 14/09/2020];48(1):10- 3. Disponible en: https://academic.oup.com/ageing/article/48/1/10/5123812

  13. Vallano Ferraz A, Agustí Escasany A, Pedrós Xolvi C, Arnau de Bolós JM. Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos. Gac Sanit. 2012;26(3):277-83.

  14. García-Milián A, Galindo-Reymod K, Morales-Pérez M, León-Cabrera P, Pando-Ferrer R. Farmacovigilancia hospitalaria Pharmacovigilance at hospital. Rev Cuba Oftalmol. 2016 [acceso 14/09/2020];4(29):688-95. Disponible en: https://www.medigraphic.com/cgibin/ new/resumenI.cgi?IDARTICULO=71109

  15. Hailu AD, Mohammed SA. Adverse Drug Reaction Reporting in Ethiopia: Systematic Review. Biomed Res Int. 2020;2020:8569314. DOI: 10.1155/2020/8569314

  16. Haines HM, Meyer JC, Summers RS, Godman BB. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district. Eur J Clin Pharmacol. 2020 [acceso 10/09/2020];76(7):991-1001. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32296857/

  17. Vallejos Narváez Á, Calvache JC, Ávila MP, Latorre SI, Ruano CA, Delgadillo J, y col. Prescripción de analgésicos y reacciones adversas en pacientes hospitalizados. Rev Colomb Ciencias Químico-Farmacéuticas. 2018 [acceso 10/09/2020];47(1):86-103. Disponible en: https://www.mendeley.com/catalogue/cf45755e-36a8-3178-912f-8a37c7e03e68/

  18. Aagaard L, Almdal T, Andersen H, Brunak S, Hansen E, Jensen P, et al. Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicines. J Res Pharm Pract. 2015 [acceso 06/09/2020];4(2):64-72. DOI: 10.4103/2279-042X.155753

  19. Machado Alba JE, Cardona Trejos EA, Sánchez Morales LV, Rodríguez Ramírez LF. Identificación de reacciones adversas por dipirona en pacientes de un hospital de tercer nivel. Ces Med. 2019 [acceso 06/09/2020];33(1):13-20. Disponible en: https://revistas.ces.edu.co/index.php/medicina/article/view/4692

  20. Salas Rojas SG, Pérez Morales ME, Meléndez López SG. Farmacovigilancia intensiva en el servicio de medicina interna del Hospital Regional No.1 del Instituto Mexicano del Seguro Social en Tijuana, B.C. Rev Mex Ciencias Farm. 2012 [acceso 06/09/2020];43(4):55-68. Disponible en: https://www.redalyc.org/pdf/579/57928311008.pdf

  21. Guadalupe S, Rojas S, Eugenia M, Morales P, Guillermo S, López M, et al. Reacciones adversas a medicamentos relacionados con ingresos y estancias hospitalarias: revisión sistemática de 2000-2011. Rev. mex. cienc. farm. 2012 [acceso 06/09/2020];43(3):19-35. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1870- 01952012000300003&lng=es

  22. Gautron G, Wentzell J, Kanji S, Nguyen T, Kobewka D, MacDonald E. Characteización of Serious Adverse Drug Reactions in Hospital to Determine Potencial Implications of Mandatory Reporting. Can J Hosp Pharm. 2018 [acceso 06/09/2020];71(5):316-23 Disponible en: https://pubmed.ncbi.nlm.nih.gov/30401998/

  23. Saavedra PA, de Azevedo Meiners MMM, Lopes LC, da Silva EV, da Silva DLM, Noronha EF, et al. Adverse drug reactions among patients admitted with infectious diseases at a Brazilian hospital. Rev Soc Bras Med Trop. 2016 [acceso 06/09/2020];49(6):763-67. Disponible en: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037- 86822016000600763




2020     |     www.medigraphic.com